Insulin degludec significantly improves blood sugar control compared with insulin glargine, data show

Using electronic health record data, researchers found that HbA1c levels declined by 1.5% among insulin degludec-treated patients compared with 1.2% in those treated with insulin glargine U300 over six months.
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research